Melody Rivera-Hernández
About
Research
Publications
2026
Advancing substance use disorder biology by studying underlying gene x environment interactions
Sidamon-Eristoff A, Rivera-Hernandez M, Huckins L, Montalvo-Ortiz J, Brennand K. Advancing substance use disorder biology by studying underlying gene x environment interactions. Current Opinion In Genetics & Development 2026, 97: 102443. PMID: 41702263, PMCID: PMC12919645, DOI: 10.1016/j.gde.2026.102443.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsIntravenous Delivery of a Gene Therapy Vector that Expresses an Antitransferrin Receptor 1 Nanobody-I2S Fusion Protein Rescued Central Nervous System Lysosomal Burden in Mucopolysaccharidosis II Mice
Ruangsiriluk W, Jacobo S, Iskenderian A, Modi M, Chen N, Felice B, Yuan S, Mukherji S, Hernandez M, Sunkara S, MacDonald A, Rajarshi G, Palmieri K, Crooker R, Wu R, Dalrymple M, Chheda M, Megahid D, Arce C, Shen M, Dasari B, Zhao X, Yalavarthi M, Rompikuntal P, Ayyadurai S, Fang J, Hozanovic A, Pescatore B, Bassous D, Romashko A, Galbreath E, Maccani A, Steinkellner J, Ehmann D, Choi V, Islam R. Intravenous Delivery of a Gene Therapy Vector that Expresses an Antitransferrin Receptor 1 Nanobody-I2S Fusion Protein Rescued Central Nervous System Lysosomal Burden in Mucopolysaccharidosis II Mice. Human Gene Therapy 2026, 37: 130-142. PMID: 41457681, DOI: 10.1177/10430342251406283.Peer-Reviewed Original ResearchAdministration, IntravenousAnimalsBlood-Brain BarrierBrainCentral Nervous SystemDependovirusDisease Models, AnimalEnzyme Replacement TherapyGenetic TherapyGenetic VectorsGlycosaminoglycansHumansIduronate SulfataseLysosomesMiceMice, KnockoutMucopolysaccharidosis IIReceptors, TransferrinRecombinant Fusion ProteinsSingle-Domain Antibodies
2025
Corrigendum: A novel assay of excess plasma kallikrein-kinin system activation in hereditary angioedema
Sexton D, Faucette R, Rivera-Hernandez M, Kenniston J, Papaioannou N, Cosic J, Kopacz K, Salmon G, Beauchemin C, Juethner S, Yeung D. Corrigendum: A novel assay of excess plasma kallikrein-kinin system activation in hereditary angioedema. Frontiers In Allergy 2025, 6: 1557356. PMID: 40027353, PMCID: PMC11867937, DOI: 10.3389/falgy.2025.1557356.Commentaries, Editorials and Letters